European stocks finished lower on Friday, but registered a second straight weekly gain, after U.S. President Donald Trump threatened China with additional tariffs.
The White House announcement unsettled markets, ratcheting up the possibility of a prolonged trade conflict, after a week of tit-for-tat moves by Washington and Beijing.
How markets are movingThe Stoxx Europe 600 index SXXP, -0.35% slipped 0.4% to 374.82, erasing a small part of a 2.4% rise logged on Thursday, when the index rallied to its best one-day percentage gain since June 19, 2016 on an easing in trade-war worries. For the week, the pan-Europe gauge rose 1.1%, marking its second weekly rise in a row.
Top China Stocks To Buy Right Now: Clean Diesel Technologies Inc.(CDTI)
Advisors' Opinion:- [By Stephan Byrd]
Here are some of the media stories that may have impacted Accern Sentiment’s analysis:
Get Molecular Templates alerts: Trading Center: Watching the Levels for Molecular Templates, Inc. (:MTEM): Move of 0.02 Since the Open (stocknewscaller.com) Molecular Templates (MTEM) Announces Clinical Data at 2018 ASCO Meeting (streetinsider.com) Gallbladder Cancer Treatment Sales Market Size by Players, Regions, Type, Application and Forecast to 2025 (exclusivereportage.com) ATR in spotlight EnSync, Inc. (NYSE:ESNC), CDTi Advanced Materials, Inc. (NASDAQ:CDTI), Molecular Templates, Inc … (stocksnewspoint.com)MTEM has been the subject of several research analyst reports. ValuEngine lowered shares of Molecular Templates from a “hold” rating to a “sell” rating in a research report on Thursday, March 1st. Zacks Investment Research raised shares of Molecular Templates from a “sell” rating to a “hold” rating in a research report on Thursday, June 7th. Four analysts have rated the stock with a hold rating and one has given a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $5.20.
Top China Stocks To Buy Right Now: Focus Media Holding Limited(FMCN)
Advisors' Opinion:- [By Stephan Byrd]
An issue of Focus Media Holding Limited (NASDAQ:FMCN) debt fell 1.1% against its face value during trading on Tuesday. The debt issue has a 7.5% coupon and is set to mature on April 1, 2025. The debt is now trading at $97.63 and was trading at $98.50 last week. Price changes in a company’s debt in credit markets sometimes anticipate parallel changes in its stock price.
Top China Stocks To Buy Right Now: Netease.com Inc.(NTES)
Advisors' Opinion:- [By Leo Sun]
For comparison, Tencent (NASDAQOTH:TCEHY) and NetEase (NASDAQ:NTES), the two biggest names in Chinese mobile games, trade at about 9 times and 3 times this year's sales, respectively. Out of the ten highest-grossing Android games in China (according to Newzoo's April numbers), Tencent and its subsidiaries published six of the titles, while NetEase published three. The only game which didn't come from those two publishers was 4399's Dream Journey.�
- [By Leo Sun]
Shares of NetEase (NASDAQ:NTES) recently tumbled after the Chinese tech company posted mixed first-quarter numbers. Its revenue rose 4% annually to 14.2 billion yuan ($2.3 billion), which beat estimates by $120 million. Unfortunately, its non-GAAP net income plunged 69% to 1.34 billion yuan ($213 million), or $1.61 per diluted ADS (American depositary share) -- which missed estimates by 36 cents.
- [By Dan Caplinger]
Thursday was a relatively quiet day on Wall Street, and action in different parts of the market showed mixed signals for investors. On one hand, small-cap stocks moved higher, with key benchmarks in that area hitting record highs. Yet the better-known large-cap stock indexes like the S&P 500 gave up early gains. Looking more closely at individual stocks, some companies suffered from bad news that sent their shares falling. J.C. Penney (NYSE:JCP), NetEase (NASDAQ:NTES), and Jounce Therapeutics (NASDAQ:JNCE) were among the worst performers on the day. Here's why they did so poorly.
- [By Shane Hupp]
News articles about NetEase (NASDAQ:NTES) have been trending somewhat positive this week, Accern reports. Accern ranks the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. NetEase earned a media sentiment score of 0.23 on Accern’s scale. Accern also assigned news coverage about the technology company an impact score of 47.5808045346287 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Top China Stocks To Buy Right Now: Baidu Inc.(BIDU)
Advisors' Opinion:- [By Keith Fitz-Gerald]
Take China, for example. It's long been one of the president's favorite targets, yet the nation's companies are stepping onto the global stage far faster than most Westerners can comprehend. Alibaba Group Holding Ltd. (NYSE: BABA), for example, threatens Amazon.com Inc. (Nasdaq: AMZN) in key markets around the world. Baidu Inc. (Nasdaq: BIDU) is gearing up for a fight with Alphabet Inc. (Nasdaq: GOOGL).
- [By Leo Sun]
Shares of Baidu (NASDAQ:BIDU) tumbled 10% on May 18, after the�company announced the upcoming departure of COO Qi Lu in July. Prior to joining Baidu in early 2017, Lu served as�Microsoft's executive VP of its Applications and Services Group. As one of the industry's leading AI experts, Lu played a key role in Baidu's transition from an online search company to a cloud and AI services provider.
- [By Lisa Levin] Gainers Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8. Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica. DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance. eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results. Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results. SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results. Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results. Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36. Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday. ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial. Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70. Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday. Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M
- [By Anders Bylund]
iQiyi�(NASDAQ:IQ) had a good day on Friday. Shares of the Chinese online media giant and former Baidu (NASDAQ:BIDU) subsidiary were up 11.1% at 3:40 p.m. EDT. An iQiyi-produced movie was nominated for two prestigious awards at the Shanghai International Film Festival, which is a lot like an up-and-coming Western studio snagging some Oscar nods.
- [By Leo Sun]
Baidu (NASDAQ:BIDU) recently authorized a buyback of up�to $1 billion in shares over the next 12 months. The buyback, which will be funded with the company's existing cash, could reduce Baidu's float by about 1% based on its current market cap of $85 billion.
- [By Brian Stoffel]
Chinese search giant�Baidu�(NASDAQ:BIDU) went public in 2005. After stumbling out of the IPO gate, it experienced the type of run-up that can create dynastic wealth for patient investors. Between early 2006 and mid-2011, shares of the company advanced 3,000%. In other words, in just five years, you could have turned a $10,000 investment into $300,000!
No comments:
Post a Comment